Gary Gemignani
Director/Board Member bei BLUEJAY DIAGNOSTICS, INC.
Vermögen: 1 104 $ am 31.03.2024
Profil
Gary G.
Gemignani is currently serving as an Independent Director at Bluejay Diagnostics, Inc., a Director at Algorithm Sciences, Inc., a Director at Laidlaw Venture Partners, and the Chief Financial Officer & EVP at Solta Medical, Inc. He previously held positions as a Director at IASO Pharma, Inc. from 2010 to 2012, the Chief Financial Officer & Executive Vice President at Gentium Srl, the Chief Financial Officer at Biodel, Inc. from 2014 to 2016, the Executive VP, Chief Operating & Financial Officer at Fortress Biotech, Inc. from 2010 to 2011, the Chief Financial Officer & Executive Vice President at Champions Oncology, Inc. from 2011 to 2013, the Chief Financial Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2017 to 2019, the Chief Financial Officer & Executive Vice President at Acacia Pharma Group Ltd.
from 2020 to 2022, and the Chief Financial Officer at Albireo Pharma, Inc. He obtained his undergraduate degree from Saint Peter's University in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.05.2023 | 1 375 ( 0,11% ) | 1 104 $ | 31.03.2024 |
Aktive Positionen von Gary Gemignani
| Unternehmen | Position | Beginn |
|---|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Director/Board Member | 15.11.2021 |
Laidlaw Private Equity, LLC
 Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Venture Partners (Laidlaw Venture) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd. The firm is headquartered in New York. | Director/Board Member | 04.10.2021 |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Director/Board Member | 04.10.2021 |
Solta Medical, Inc.
 Solta Medical, Inc. Medical SpecialtiesHealth Technology Solta Medical, Inc. designs, develops, manufactures and markets energy-based medical device systems for aesthetic applications. Its brands include Clear + Brilliant pélo, Thermage, Liposonix, VASER, Fraxel, Clear + Brilliant, and Isolaz systems which are used to address various aesthetic issues. The company was founded by Edward W. Knowlton on January 11, 1996 and is headquartered in Pleasanton, CA. | Director of Finance/CFO | 01.01.2022 |
Ehemalige bekannte Positionen von Gary Gemignani
| Unternehmen | Position | Ende |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Director of Finance/CFO | 23.03.2022 |
| SYNERGY PHARMACEUTICALS INC | Director of Finance/CFO | 01.07.2019 |
| CHAMPIONS ONCOLOGY, INC. | Director of Finance/CFO | 30.06.2013 |
| FORTRESS BIOTECH, INC. | Director of Finance/CFO | 26.09.2011 |
| GENTIUM S.P.A. (ADR) | Director of Finance/CFO | 31.03.2010 |
Ausbildung von Gary Gemignani
| Saint Peter's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| BLUEJAY DIAGNOSTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology IASO Pharma, Inc. operated as a development stage biopharmaceutical company which focused on acquiring, developing and commercializing drugs for the treatment and prevention of infectious diseases and other serious illnesses. The company was founded on October 5, 2006 and is headquartered in San Diego, CA. | Health Technology |
Solta Medical, Inc.
Solta Medical, Inc. Medical SpecialtiesHealth Technology Solta Medical, Inc. designs, develops, manufactures and markets energy-based medical device systems for aesthetic applications. Its brands include Clear + Brilliant pélo, Thermage, Liposonix, VASER, Fraxel, Clear + Brilliant, and Isolaz systems which are used to address various aesthetic issues. The company was founded by Edward W. Knowlton on January 11, 1996 and is headquartered in Pleasanton, CA. | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Algorithm Sciences, Inc.
Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Health Technology |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Venture Partners (Laidlaw Venture) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd. The firm is headquartered in New York. | Finance |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
